In Vitro Antiviral Activity and Mode of Action of JNJ-64530440, a Novel Potent Hepatitis B Virus Capsid Assembly Modulator in Clinical Development
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Jan Martin Berke1, Pascale Dehertogh1, Karen Vergauwen1, Thierry Verbinnen1, Sandrine Vendeville1, Pierre Raboisson1 and Frederik Pauwels1
1Janssen Research & Development, Janssen Infectious Diseases, Beerse, Belgium
